7
Participants
Start Date
April 30, 2013
Primary Completion Date
April 30, 2015
Study Completion Date
April 30, 2016
Eltrombopag
Study patients will be provided eltrombopag to raise platelet levels before anti-hepatitis C drugs are initiated, and will continue eltrombopag throughout the study.
UT Southwestern Medical Center, Dallas
Collaborators (1)
GlaxoSmithKline
INDUSTRY
University of Texas Southwestern Medical Center
OTHER